Optimal Use of Sandimmun® in Nephrotic Syndrome

Optimal Use of Sandimmun® in Nephrotic Syndrome by A. Meyrier, P. Niaudet, J. Brodehl.

Since 1978, when Sandimmun was first used in humans, great experience has been gathered in clinical transplantation by the treatment of about half a million patients. The experience with Sandimmun in nephrotic syndrome is put into perspective and compared with alternatives such as corticosteroids an...

Full description

Saved in:
Bibliographic Details
Main Authors: Meyrier, A. (Author), Niaudet, P. (Author), Brodehl, J. (Author)
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1992.
Edition:1st ed. 1992.
Series:Springer eBook Collection.
Subjects:
Nephrology.
Pharmacology.
Allergy.
Immunology.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • 1 Introduction
  • 2 Background
  • 2.1 The glomerulus and the glomerular barrier to proteins
  • 2.2 Nephrotic syndrome
  • 2.3 Mode of action of Sandimmun in NS
  • 3 Idiopathic nephrotic syndrome (nephrosis)
  • 3.1 Minimal change disease
  • 3.2 Focal segmental glomerulosclerosis
  • 3.3 Treatment of nephrosis
  • 4 Idiopathic membranous glomerulopathy
  • 4.1 Definition
  • 4.2 Clinical course
  • 4.3 Treatment
  • 5 Sandimmun in other etiologies of nephrotic syndrome
  • 5.1 Lupus nephritis
  • 5.2 IgA nephropathy
  • 5.3 Proliferative glomerulonephritis
  • 5.4 Other glomerulopathies
  • 6 Guidelines for the use of Sandimmun in nephrotic syndrome
  • 6.1 Patient selection
  • 6.2 Dosage
  • 6.3 Monitoring
  • References.

Similar Items